ractigen In News Highlight04/03/24 Ractigen Announces First Patient Dosed in the Phase I Clinical Trial of RAG-01 for NMIBC JIANGSU, China, April 3, 2024 – Ractigen Therapeutics, a pioneer in small activating RNA (saRNA) therapeutics,…Read More